Hot Link

NPC Deputy Proposes Law on Genetically-Engineered Medicines

A law on the management of genetically-engineered medicines needs to be enacted to promote and systematically standardize the research, development, utilization and transfer of China's genetically-engineered medicines as well as the management of production, sales and safety of such products, according to a motion tabled to the current annual session of the NPC.

The motion was tabled jointly by a group of NPC deputies headed by Prof. Kong Fanchao, president of the mathematics and physics college of Anhui University.

Kong said the genetic technologies are expected to provide a most effective approach to diagnosing diseases, developing new medicines and exploring new cures of diseases.

He said that Chinese scientists have developed gene-transferred test-tube cows, which carry human serum protein genes and can produce milk containing human serum protein. At present, at least 15 varieties of genetically-engineered medicines are on sale in China.

In the United States, however, more than 50 kinds of genetically-engineered medicines are on sale, and 350 are under examination and approval and 2,200 other are being developed.

He suggested that the state take an active attitude toward the R&D of genetically-engineered medicines while being cautious concerning the commercialization of such production.

(Xinhua 03/12/2001)

In This Series

Scientists Find Genes of Arterial Sickness

China on Par with Developed Countries in Genome Research

Ministry Closes Online 'Clinics'

Online Medicine Under Stricter Control

Transgenic Sheep Born in Beijing



Web Link